Zobrazeno 1 - 10
of 212
pro vyhledávání: '"Drug sensitivity testing"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Tumor organoids, an in-vitro three-dimensional model, possess high potential for investigating tumor biology and treatment response and have been demonstrated more appropriate for drug assessment than two-dimensional cultures. Herein, we described tw
Externí odkaz:
https://doaj.org/article/3fe2db0a8dfd4ac995c28d43d7f665f4
Autor:
Talent C. Dlamini, Brenda T. Mkhize, Clive Sydney, Nontuthuko E. Maningi, Lesibana A. Malinga
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background The tuberculosis (TB) epidemic remains a major global health problem and Eswatini is not excluded. Our study investigated the circulating genotypes in Eswatini and compared them at baseline (start of treatment) and follow-up durin
Externí odkaz:
https://doaj.org/article/602d9479768240a48c4aa3b3190ca6b4
Autor:
Bony Wiem Lestari, Gerine Nijman, Alamanda Larasmanah, Arto Yuwono Soeroto, Prayudi Santoso, Bachti Alisjahbana, Lidya Chaidir, Basti Andriyoko, Reinout van Crevel, Philip C. Hill
Publikováno v:
The Lancet Regional Health - Southeast Asia, Vol 22, Iss , Pp 100294- (2024)
Summary: Background: In Indonesia, drug resistance testing for TB largely relies on Xpert MTB/RIF, and it is unknown what proportion of drug-resistant (DR) TB is adequately diagnosed and treated. Methods: We conducted a cascade of care analysis on a
Externí odkaz:
https://doaj.org/article/07a384a50a2e46d4b6715864513851e9
Autor:
Atnafu A, Wassie L, Tilahun M, Girma S, Zenebe Y, Beyene MA, Alemu A, Fisseha E, Agze H, Desta T, Desta K, Bobosha K
Publikováno v:
Infection and Drug Resistance, Vol Volume 16, Pp 3453-3461 (2023)
Abay Atnafu,1 Liya Wassie,1 Melaku Tilahun,1,* Selfu Girma,1 Yohannes Zenebe,2 Muluye Abebe Beyene,1 Ashenafi Alemu,1 Emnet Fisseha,1 Haymanot Agze,1 Tigist Desta,1 Kassu Desta,3,* Kidist Bobosha1,* 1Armauer Hansen Research Institute, Add
Externí odkaz:
https://doaj.org/article/5b0fba71bdeb4eeaaf811c0aeda4a4de
Autor:
Dale M. Walker, Tsvetelina I. Lazarova, Steven W. Riesinger, Miriam C. Poirier, Terri Messier, Brian Cunniff, Vernon E. Walker
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
The lack of anticancer agents that overcome innate/acquired drug resistance is the single biggest barrier to achieving a durable complete response to cancer therapy. To address this issue, a new drug family was developed for intracellular delivery of
Externí odkaz:
https://doaj.org/article/f4c45ff1604b44f9a8e00b84babc041b
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Objective: This study was developed to assess the in vivo antimicrobial activity of specific drugs using a model system consisting of Caenorhabditis elegans (C. elegans) infected with Carbapenem-resistant Klebsiella pneumoniae (CRKP) in an effort to
Externí odkaz:
https://doaj.org/article/1da03fc831614d3d9219fd01bb67e89b
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 16, Iss 7, Pp DE01-DE05 (2022)
India has made a bold promise to eradicate Tuberculosis (TB) by 2025 five years ahead of the global target. Although, one-fourth of the global burden with highest new cases of TB is shown by the country. So yet, no comprehensive analysis has been pub
Externí odkaz:
https://doaj.org/article/d3cc80ce26214d38a468672c446d879d
Autor:
Da-Yong Lu, Ting-Ren Lu
Publikováno v:
Advances in Biomarker Sciences and Technology, Vol 2, Iss , Pp 59-66 (2020)
Cancer treatments become more effective now. One cause of these therapeutic promotions is based on drug selective paradigms in the clinic. A small range of drug selective paradigms (pharmacogenomics, precision-oncology, biomarkers and drug sensitivit
Externí odkaz:
https://doaj.org/article/56eb12231c3049339011710a58e28d40
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.